Mesoblast (MESO) EBT Margin (2016 - 2023)

Mesoblast's (MESO) quarterly EBT Margin came in at 409.53% in Q2 2023, up 104283.0% year-on-year from N/an in Q2 2022, and up 142.59% quarter-over-quarter from 961.63% in Q1 2023.

Mesoblast (MESO) EBT Margin (2016 - 2023) Analysis & Trends

Mesoblast has disclosed EBT Margin across 8 years of filings, most recently posting 409.53% for Q2 2023.

  • EBT Margin for Q2 2023 came in at 409.53%, up 104283.0% year-over-year; the trailing twelve-month figure through Mar 2023 was 932.28% (up 11419.0% YoY), and the FY2025 annual result was 592.0%, changed N/A from the prior year.
  • EBT Margin came in at 409.53% for Q2 2023 at Mesoblast, up from 961.63% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 409.53% in Q2 2023 to a low of 2607.97% in Q1 2019.
  • The 5-year median for EBT Margin is 1100.52% (2021), against an average of 1043.66%.
  • Peak annual rise in EBT Margin reached 178057 bps in 2020, while the deepest fall reached 154055 bps in 2020.
  • Mesoblast's EBT Margin stood at 1363.79% in 2019, then climbed by 16 bps to 1143.15% in 2020, then grew by 4 bps to 1092.57% in 2021, then retreated by 14 bps to 1240.25% in 2022, then jumped by 133 bps to 409.53% in 2023.
  • The last three EBT Margin figures came in at 409.53% (Q2 2023), 961.63% (Q1 2023), and 1240.25% (Q4 2022), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 6.40%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 41.95%
9 Abivax 91.96 Bn 91.96 Bn - -
10 Mesoblast 21.68 Bn 21.55 Bn - -

Historic Data

Download Data
DateValue
Jun 30, 2023 409.53%
Mar 31, 2023 -961.63%
Dec 31, 2022 -1,240.25%
Sep 30, 2022 -1,173.87%
Jun 30, 2022 -633.30%
Mar 31, 2022 -1,061.51%
Dec 31, 2021 -1,092.57%
Sep 30, 2021 -937.53%
Jun 30, 2021 -1,108.47%
Mar 31, 2021 -1,359.19%
Dec 31, 2020 -1,143.15%
Sep 30, 2020 -1,936.70%
Jun 30, 2020 -136.72%
Mar 31, 2020 -827.39%
Dec 31, 2019 -1,363.79%
Sep 30, 2019 -396.15%
Jun 30, 2019 -1,215.20%
Mar 31, 2019 -2,607.97%
Dec 31, 2018 -2,257.11%
Sep 30, 2018 -2,008.85%